NCT06566404View on ClinicalTrials.gov

Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

October 30, 2024

Primary Completion Date

July 1, 2027

Study Completion Date

January 1, 2028

Conditions

Melanoma

All Listed Sponsors

lead

European Institute of Oncology

OTHER

NCT06566404 - Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma | Biotech Hunter | Biotech Hunter